New web portal highlights UK strengths in medicines manufacturing
pharmafile | December 1, 2015 | News story | Manufacturing and Production | ABPI, KTN, Knowledge Transfer Network, Medicines Manufacturing Industry Partnership, UK, manufacturing, mmip, production
A new web portal has been launched to provide a platform to promote the UK’s strengths and capabilities in medicines manufacturing.
The portal is developed by the Knowledge Transfer Network (KTN), on behalf of the Medicines Manufacturing Industry Partnership (MMIP). Demand for the portal arose when research showed there is confusion about UK’s activity in this sector, in terms of the current industry base, academic research, and support for innovation in medicines manufacturing.
The new portal is the first interactive tool to pull together the innovation landscape, company base and manufacturing sites for the entire medicines sector within the country.
The MMIP was jointly established by the ABPI and the BioIndustry Association (BIA), with involvement from pharma and research companies including Actavis and Allergan, AstraZeneca, Eisai, GlaxoSmithKline, ReNeuron and Pfizer.
Though the partnership, the medicines manufacturing industry collaborates with government with the goal of creating an attractive and innovation-driven environment to ensure the UK remains competitive in medicines manufacturing.
Alison Clough, acting chief executive of the ABPI, comments: “The web portal should increase understanding of the UK’s medicines manufacturing capability and expertise, as well as helping to showcase the strength of UK manufacturing. It will be a helpful source of information for policy makers, pharmaceutical companies and international investors.”
George Freeman MP, Minister for life sciences, says: “Innovation in medicines manufacturing is making this a hugely exciting and important strategic sector for UK life science. The UK has a world-class offer for businesses built on access to leading science and the ability to tap into national resources to innovate manufacturing processes, for example through the National Biologics Manufacturing Centre, the Cell Therapy Catapult and Manufacturing Centre and the Precision Medicine Catapult.
“This new portal explains in one place what resources there are to support businesses involved in medicines manufacturing, making it easier to get the information they need, find companies they might want to engage with across supply chains, and see live information on access to finance.”
Ian McCubbin, who is chair of the Medicines Manufacturing Industry Partnership, adds: “The UK has a strong and vibrant medicines manufacturing base and it is vital that we sustain and grow this by using the considerable support, infrastructure and initiatives that can accelerate innovation and growth in the UK. Our sector has called for assistance in understanding how to navigate the innovation landscape and I believe that this KTN portal provides great value to our sector in the UK and globally.”
Joel Levy
The portal can be found at: www.mmlandscape.ktn-uk.org.
Related Content
Addenbrooke’s hospital offers first self-service digital eye test
Addenbrooke’s Hospital, Cambridge, has become the first in the UK to deploy a digital self-testing …
Digital Control Room, a major pharma provider, wins King’s Award for Enterprise
Buckingham Palace has announced that Digital Control Room, a software platform that monitors companies’ online …
Deadly cancers are being financially left behind, new research claims
New research has revealed that some of the UK’s most deadly and prevalent cancers receive …
